FindTrial
Sign In

A Phase I double blinded, single-center, randomized, crossover study comparing the PK, PD, safety and tolerability of a single IV dose (1µg/kg) of LB-0702 and Nplate® in healthy volunteers.

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518285-27-00
Acronym
RJ-ROM01
Enrollment
34
Registered
2025-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not applicable (submitted trial is a bioequivalence study)

Interventions

None listed

Sponsors

Laboratorio Reig Jofre S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026